Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults

We conducted a phase II study of the combination of temozolomide and angiogenesis inhibitors for treating adult patients with newly diagnosed glioblastoma. Patients who had stable disease following standard radiation therapy received temozolomide for 5 days in 28-day cycles, in combination with dail...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kesari, Santosh, Schiff, David, Henson, John W., Muzikansky, Alona, Gigas, Debra C., Doherty, Lisa, Batchelor, Tracy T., Longtine, Janina A., Ligon, Keith L., Weaver, Susan, Laforme, Andrea, Ramakrishna, Naren, Black, Peter McL., Drappatz, Jan, Ciampa, Abigail, Folkman, Judah, Kieran, Mark, Wen, Patrick Y.
Médium: Artigo
Jazyk:Inglês
Vydáno: Duke University Press 2008
Témata:
Clinical Investigations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2563052/
https://ncbi.nlm.nih.gov/pubmed/18403492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2008-005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky